The findings in breast cancer survivors are ‘reassuring,’ given the benefit of aromatase inhibitors, the authors say. The study was published as a preprint and has not yet been peer reviewed.
First Look
No CVD Issues Apparent Years After Aromatase Inhibitor Therapy
